Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7591778

Concept 2022-04-01 to
2022-06-30
2021-04-01 to
2021-06-30
Consolidated statement of income
Statement of income
Net sales
106,000 JPY
212,000 JPY
Operating expenses
Selling, general and administrative expenses
545,503,000 JPY
402,732,000 JPY
Operating expenses
Cost of sales
26,000 JPY
53,000 JPY
Ordinary profit (loss)
-548,221,000 JPY
-403,904,000 JPY
Operating profit (loss)
-545,423,000 JPY
-402,573,000 JPY
Net sales
Gross profit (loss)
79,000 JPY
159,000 JPY
Non-operating income
308,000 JPY
8,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating income
Other
308,000 JPY
8,000 JPY
Extraordinary income
JPY
4,455,000 JPY
Non-operating expenses
Other
61,000 JPY
JPY
Non-operating expenses
3,106,000 JPY
1,339,000 JPY
Share issuance costs
617,000 JPY
562,000 JPY
Extraordinary losses
JPY
2,933,000 JPY
Impairment losses
JPY
2,896,000 JPY
Profit (loss) before income taxes
-548,221,000 JPY
-402,383,000 JPY
Gross profit
Extraordinary income
Income taxes - current
475,000 JPY
605,000 JPY
Extraordinary losses
Loss on retirement of non-current assets
JPY
37,000 JPY
Income taxes
475,000 JPY
605,000 JPY
Profit (loss)
-548,696,000 JPY
-402,988,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.